Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

NCT: NCT06700460 · COMPLETED

NCT IDNCT06700460
StatusCOMPLETED
Start Date2024-11-27
Completion2025-11-13
SponsorVance Thompson Vision (OTHER)
First posted
Last updated

Brief Summary

Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

Frequently Asked Questions

What is Measuring Outcomes of LASIK and EVO-ICL in Matched Populations?

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations is a clinical trial registered under NCT06700460. Current status: COMPLETED.

What is the status of NCT06700460?

The current status of NCT06700460 (Measuring Outcomes of LASIK and EVO-ICL in Matched Populations) is: COMPLETED.

When did Measuring Outcomes of LASIK and EVO-ICL in Matched Populations start?

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations started on 2024-11-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.